RxElite, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RXEI research report →
Companywww.piramalcriticalcare.com
RxElite, Inc. engages in the development, manufacture, and marketing of generic prescription drug products in specialty generic markets. Its products include Sterile Liquid Dose products that consist of generic ophthalmic products in unit and multi-dose presentations, sterile unit dose inhalation respiratory products, and injectable drugs.
- CEO
- Richard Tener
- IPO
- 2020
- Employees
- 47
- HQ
- Meridian, ID, US
Price Chart
Valuation
- Market Cap
- $1.48K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 0.58
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 5.12%
- Op Margin
- 436.80%
- Net Margin
- -610.52%
- ROE
- -273.67%
- ROIC
- 84.12%
Growth & Income
- Revenue
- $2.81M · 138.97%
- Net Income
- $-17,165,275 · -18363.65%
- EPS
- $-0.27 · -3100.00%
- Op Income
- $12.28M
- FCF YoY
- -25487.88%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 6.40
- Avg Volume
- 112.852
Get TickerSpark's AI analysis on RXEI
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 4, 08 | RECTOR DAVID | other | 100,000 |
| Jun 4, 08 | RECTOR DAVID | other | 1,000,000 |
| Jun 4, 08 | RECTOR DAVID | sell | 400,000 |
| Jun 4, 08 | AUERBACH MARK | other | 100,000 |
| Jun 4, 08 | AUERBACH MARK | other | 1,000,000 |
| Jun 4, 08 | AUERBACH MARK | sell | 400,000 |
| Oct 11, 07 | RECTOR DAVID | other | 400,000 |
Our RXEI Coverage
We haven't published any research on RXEI yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate RXEI Report →